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Invasive infections with Mycobacterium chimaera were 
reported in patients with previous open chest surgery 
and exposure to contaminated heater-cooler units 
(HCUs). We present results of the surveillance of clini-
cal cases and of contaminated HCUs as well as envi-
ronmental investigations in Germany up until February 
2016. Clinical infections occurred in five male German 
cases over 50 years of age (range 53–80). Cases had 
been exposed to HCUs from one single manufacturer 
during open chest surgery up to five years prior to 
onset of symptoms. During environmental investiga-
tions, M. chimaera was detected in samples from used 
HCUs from three different countries and samples from 
new HCUs as well as in the environment at the man-
ufacturing site of one manufacturer in Germany. Our 
investigation suggests that at least some of the M. 
chimaera infections may have been caused by contam-
ination of HCUs at manufacturing site. We recommend 
that until sustainable measures for safe use of HCUs 
in operation theatres are implemented, users continue 
to adhere to instructions for use of HCUs and Field 
Safety Notices issued by the manufacturer, implement 
local monitoring for bacterial contamination and con-
tinuously check the websites of national and European 
authorities for current recommendations for the safe 
operation of HCUs.
Introduction
In July 2014, the Federal Office of Public Health 
Switzerland (FOPH) reported about patients with 
Mycobacterium chimaera infections, who had previ-
ously undergone open-chest heart surgery with expo-
sure to contaminated heater-cooler units (HCUs) [1]. 
Several other reports and publications have suggested 
since that HCUs produced by one manufacturer in 
Germany may be a source of M. chimaera infections 
that occurred in Switzerland, Germany, the Netherlands 
and United Kingdom [2-5].
HCUs are commonly used in cardiac surgery during 
extracorporeal circulation in order to regulate the tem-
perature of the blood and to provide temperature-con-
trolled water for cardioplegia. HCUs have water tanks 
that provide temperature-controlled water to external 
heat exchangers. Since M. chimaera was detected in 
air samples close to operating HCUs, airborne trans-
mission is believed to be the most likely transmission 
mechanism in the M. chimaera cases after open chest 
surgery [4,6].
M. chimaera is a slow-growing nontuberculous myco-
bacterium (NTM) belonging to the M. avium complex 
(MAC). It was first reported by Tortoli et al. in 2004 as 
a closely to M. intracellulare-related distinct species 
[7]. Identification requires molecular diagnostic testing 
[8]. M. chimaera may cause lung infections especially 
in patients with underlying lung disease as well as dis-
seminated infections in immunocompromised patients 
and was found in skin and bone infections. In the envi-
ronment, it was identified in biofilms and detected in 
water sources such as household water [9].
Among others, the report by the FOPH about the out-
break investigations in Switzerland and the reports 
about cases in Germany and the Netherlands led to 
increased surveillance efforts and outbreak investiga-
tions in Europe [3,10]. Here we present the results of 
the surveillance of clinical cases, of the surveillance 





For our investigations we used the following case defi-
nitions: a confirmed case was defined as a patient 
having undergone surgery with extracorporeal circula-
tion in the five years before onset of symptoms of NTM 
infection AND in whom M. chimaera was detected in an 
invasive sample (e.g. blood, tissue biopsy or implanted 
prosthetic material). A probable case was defined as a 
confirmed case, but without detection of M. chimaera 
in an invasive sample.
An HCU was considered as contaminated, when cardiac 
surgery centres found NTM and/or other bacteria from 
environmental samples from the HCU and sent a report 
to the Federal Institute for Drugs and Medical Devices 
(BfArM) in Germany.
Prospective case finding and identification of 
contaminated HCUs
Prospective case finding was conducted from April 
2015 onwards and results until end February 2016 are 
presented here. The mandatory surveillance of health-
care-associated outbreaks in Germany was applied 
for reporting clinical cases and this surveillance is 
described in detail elsewhere [11].
The public health authorities and healthcare profes-
sionals in Germany were informed about the ongoing 
outbreak and requested to notify cases fulfilling the 
case definition [12]. Specifically, the German National 
public health institute (Robert Koch Institute (RKI)), 
the German Society of Thoracic and Cardiovascular 
Surgery and the German Society of Infection informed 
federal states’ authorities and societies’ members, 
respectively, about case definitions and notification 
according to the article 6 of the ‘Protection against 
Infection Act’ (Infektionsschutzgesetz, IfSG) [12-15].
The mandatory notification system for incident 
reports of medical devices was used to detect con-
taminated HCUs in Germany. Incident reports were 
collected and analysed by BfArM in accordance 
with the corresponding legal framework ’The Act 
on Medical Devices’ (Medizinproduktegesetz) and 
‘The Medical Device Safety Plan’ (Medizinprodukte 
Sicherheitsplanverordnung).
HCU users were requested to submit any incident 
report associated with HCUs to BfArM [16]. On 10 July 
2015, the BfArM recommended to place HCUs outside 
of the operation theatre and monitoring of contamina-
tion in HCUs [17].
At the European level, the European Centre for Disease 
Prevention and Control (ECDC) assessed the risk of 
invasive cardiovascular infection by M. chimaera 
potentially associated with heater-cooler units used 
during cardiac surgery in Europe also, in April 2015 [10]. 
The risk assessment was forwarded to regional German 
public health authorities. From April 2015 onwards, 
ECDC also provided a platform for exchange of infor-
mation and a protocol for case detection and environ-
mental testing [18]. The protocol was shared with all 
European Union/European Economic Area (EU/EEA) 
countries with the purpose to obtain information in a 
harmonised way, to further investigate the association 
between invasive infection by M. chimaera and HCUs, 
and to allow assessing the burden of these infections. 
The protocol was shared with the German heart surgery 
centres that detected clinical cases.
Table 1



















1 80 Male A Aortic valve replacement Yes Endocarditis No < 1
2 75 Male B CABG No Spondylodiscitis No 5
3 65 Male C Aortic valve replacement Yes
Valvular aortic endocarditis, 
paravalvular leak and 
abscess
Yes 3
4 67 Male C CABG and aortic valve replacement Yes Paravalvular abscess
c Nob 4
5 53 Male C Aortic valve replacement Yes Endocarditis and cerebral abscesses No 3
CABG: coronary artery bypass grafting.
a Time between exposure to open chest surgery involving use of an HCU and clinical diagnosis.
b Currently in palliative care.
c Endocarditis lenta and change of aortic valve in September 2013.
3www.eurosurveillance.org
Investigation at the HCU manufacturing site 
and at the manufacturers’ service centre
In July 2015, the Bavarian Health and Food Safety 
Authority (LGL), assisted the Bavarian regulatory 
authorities with on-site investigations and took envi-
ronmental samples at the manufacturing site and in 
the service centre of the implicated manufacturer. 
Samples were taken from the production line, on-site 
tap water and from a used and disassembled HCU from 
this manufacturer in the service centre. All samples 
were sent to the National Reference Centre (NRC) for 
Mycobacteria Borstel, Germany.
On its own initiative, the HCU manufacturer conducted 
environmental sampling for NTM at the manufacturing 
site where the HCUs are assembled and in the service 
centre where used HCUs are disassembled for decon-
tamination from July 2014 onwards. Environmental 
samples were sent to a local microbiological laboratory 
and NTM isolates were submitted to the NRC in Borstel 
for further analysis.
Culturing and typing
Mycobacteria were cultured in different laboratories. 
The development of standard protocols for microbio-
logical M. chimaera diagnostic was coordinated by 
ECDC in collaboration with laboratories such as the 
NRC Borstel in Europe; these protocols were published 
by ECDC in August 2015 [18].
Next generation sequencing (NGS) of isolates is still 
ongoing.
Ethics
A formal ethical review process and approval was not 
required for this outbreak investigation in accordance 
with article 25, section 1 of the IfSG.
Results
At the beginning of our investigation, in April 2015, we 
were informed by cardiac surgery centre A in Germany 
about a confirmed case that became symptomatic 
before 2015 [3]. During April 2015 to February 2016, 
the mandatory surveillance of healthcare-associated 
outbreaks identified four additional confirmed cases 
of M. chimaera infection who had been exposed to an 
HCU in two different cardiac surgery centres (B and C) 
in Germany (Table 1). These cases developed a symp-
tomatic M. chimaera infection five months to five years 
after exposure to a HCU. All five confirmed cases were 
male and aged above 50 years (range 53–80) when 
diagnosed with M. chimaera infection, four had aortic 
valve replacement and two underwent coronary artery 
bypass grafting, one died. All had been exposed to 
HCUs from one single manufacturer during open chest 
surgery. No cases with NTM infections other than M. 
chimaera were notified. Our investigations did not 
reveal epidemiological links between cases of the dif-
ferent sites.
Between January 2015 and February 2016, the BfArM 
received 26 incident reports of contaminated HCUs 
from 16 of the total of 78 German cardiac surgery cen-
tres from different German regions. Three of the 16 
centres reported contamination of HCUs of another 
manufacturer but M. chimaera detection from these 
HCUs was not reported. Overall, the contaminations 
of the HCUs included M. chimaera and other bacteria 
such as Pseudomonas aeruginosa, Legionella pneu-
mophila and Stenotrophomonas maltophilia and fungi. 
All three centres in which German cases were exposed 
sent incident reports about contamination of HCUs 
from the same German manufacturer. Two of these 
centres reported M. chimaera detection in HCU water 
samples including one reporting also detection of M. 
chimaera in air samples. The third centre reported NTM 
in HCU water samples, results of further specification 
were not reported.
During the environmental investigations performed by 
the Bavarian regulatory authorities on 2 July 2015, six 
of 20 samples obtained were M. chimaera-positive. 
All positive samples were from one disassembled 
HCU that had been used in cardiac surgery centre D in 
Germany and was disassembled for decontamination 
in the service centre of the manufacturer. The disas-
sembled HCU was produced before modifications in 
the post-production process that were implemented 
Table 2
Mycobacterium chimaera-positive samples from environmental investigations at the manufacturing site of new HCUs and of 
used HCUs from at the manufacturer’s service centre, July 2014 to June 2015
Date Type of sample Source of sample
16 Jul 2014 Water (100 mL) Used HCU from Switzerland
29 Jul 2014 Water (100 mL) New HCU from manufacturing site
5 Aug 2014 Water (100 mL) New HCU from manufacturing site
11 Aug 2014 Water (100 mL) New HCU from manufacturing site
19 Feb 2015 Water (100 mL) Used HCU from the Netherlands
10 Jun 2015 Water (volume not specified) Sample taken in pump assembly area at the manufacturing site
HCU: heater-cooler unit.
The environmental investigations were performed by the manufacturer.
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by the manufacturer in response to the findings of M. 
chimaera contamination. The samples included in the 
investigations were water (ca 100  mL), swab and bio-
film and were collected from different sources: residual 
water, filler neck, patient bridge, biofilm from patient 
recirculation and patient bath.
In December 2015, the HCU manufacturer provided the 
RKI with information about six M. chimaera-positive 
samples from environmental investigations conducted 
between July 2014 and June 2015, including two con-
taminated HCUs from Switzerland and the Netherlands, 
respectively (Table 2).
On 22 December 2015, public health authorities in the 
EU/EEA and worldwide were notified by Germany about 
the suspected common source of M. chimaera via the 
EU Early Warning and Response System (EWRS) and via 
an International Health Regulation (IHR) notification.
Discussion
We present data that show that M. chimaera was iso-
lated in clinical samples from (i) infected patients in 
Germany who had undergone open chest surgery, (ii) in 
samples from used HCUs from three different countries 
and (iii) in samples from new HCUs and the environ-
ment at the manufacturing site of one manufacturer. 
This suggests that at least some of the five German 
cases with M. chimaera infection may have occurred 
due to contamination of the HCUs by M. chimaera at 
the manufacturing site.
Preliminary typing results indicate that the M. chimaera 
isolates detected by the authorities and the isolates 
from the manufacturer appear to be almost identical 
(unpublished data). The M. chimaera-positive environ-
mental samples at the manufacturing site prompted 
the manufacturer to modify the manufacturing process, 
which now includes ethanol disinfection and an active 
drying of the HCU water circuit before shipment. When 
the Bavarian regulatory authorities conducted onsite 
visits, no M. chimaera-positive sample was recovered 
except from a used HCU which had been disassembled 
for decontamination. The returned unit had been manu-
factured before August 2014. According to the informa-
tion provided by the manufacturer, HCUs manufactured 
before mid-August 2014 may have had environmental 
mycobacteria presence in the unit at the time of deliv-
ery. Our investigations could not elucidate if and until 
when contaminated HCUs may have been delivered to 
customers from this manufacturer.
As of end of March 2016, two additional notifications of 
patients with M. chimaera-positive clinical specimens 
are under investigation in Germany. Until now we could 
not obtain data on all surgical interventions prior the 
M. chimaera diagnosis of these patients.
A limitation of our study is that we did not conduct 
active case finding. It is likely that the passive sur-
veillance has led to an underestimation of the actual 
number of cases of M. chimaera infections in Germany. 
Furthermore, the true number of cases is probably 
underestimated since there is no typical clinical pic-
ture for infections with M. chimaera. Patients present 
with nonspecific symptoms, a variety of infection sites 
and a culture for mycobacteria is usually not part of a 
routine diagnostic work-up in patients presenting with 
signs of infection.
M. chimaera was not the only bacterial species isolated 
from HCUs. Contamination of HCUs with other bacte-
ria was reported from various cardiac surgery centres 
in Germany. Furthermore, bacteria were also isolated 
from HCUs produced by other manufacturers. It is pos-
sible that some of the cases were infected due to con-
tamination of HCUs at the cardiac surgery centres. It is 
also possible that some of the cases occurred due to 
exposure to HCUs produced by other manufacturers.
Infections by M. chimaera are rare and their occur-
rence, when detected, is considered unusual [19]. The 
reported M. chimaera infections might therefore be 
regarded as an indicator of a potential microbial haz-
ard caused by the water-bearing HCUs in the health-
care environment.
Further investigations are needed to differentiate 
between the risk of M. chimaera infection from HCUs 
contaminated at the manufacturing site, the risk of 
infection from HCUs contaminated during use and 
the risk of infection from other medical devices that 
include an HCU such as extracorporeal membrane oxy-
genators [20]. In two recent publications, Götting et 
al. and Sommerstein et al. gave interesting insights 
into possible mechanisms of airborne transmission by 
HCUs [4,6]. In the cases described here, NGS should 
help determine the fraction that may be due to contam-
ination at the manufacturing site or during use at the 
cardiac surgery centres.
To allow for targeted public health action, it is impor-
tant that manufacturers of medical products share 
the findings of their own investigations into bacte-
rial contamination, as demonstrated in this outbreak 
investigation. Sharing the results by the manufacturer, 
as well as information on the implemented corrective 
measures, allowed us to better understand the risks 
involved in HCU use. Regulatory authorities in Germany 
are continuing their information exchange with the 
manufacturers that produce HCUs to provide a sustain-
able solution for minimising the risks of infection in 
patients exposed to HCUs.
Conclusions
We present evidence on M. chimaera detection in clini-
cal samples from infected German patients having 
been exposed to HCUs produced by the same manu-
facturer, in three cardiac surgery centres, in samples 
from used HCUs from three different countries and in 
samples from new HCUs and the environment at the 
manufacturing site of one manufacturer. In summary, 
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this suggests a point source for the reported M. chi-
maera infections and for M. chimaera-positive sam-
ples from HCUs and the environment. Notifications 
of contaminated HCUs of different manufacturers and 
with various bacteria, indicate a general problem with 
water-bearing systems in the healthcare environment.
We recommend that until sustainable measures for 
a safe use of HCUs in operation theatres are imple-
mented, users continue to adhere to the instructions 
for use of the HCU and the Field Safety Notices issued 
by the manufacturer, implement a local monitoring for 
bacterial contamination of the HCUs and continuously 
check the websites of relevant national and European 
authorities for current recommendations for the safe 
operation of HCUs.
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